Content about Decongestants

July 15, 2013

Acura Pharmaceuticals on Monday announced a second-generation prototype formulation of its methamphetamine-resistant IMPEDE technology with pseudoephedrine hydrochloride yielded no measurable amount of methamphetamine hydrochloride when processed in the direct conversion or one-pot method.

July 10, 2013

The Consumer Healthcare Products Association on Wednesday applauded the Pennsylvania legislature and Gov. Tom Corbett for passage of House Bill 602, legislation requiring real-time, stop-sale technology to enable retailers to block illegal pseudoephedrine purchases at the point of sale.

June 7, 2013

The May/June 2013 Skin/itch Relief Ingredient Guide breaks down the indication, ingredients, purpose and dosage of AmLactin Moisturizing Body Lotion, CeraVe Renewing SA Cream, Olay Advanced Healing, Curel Itch Defense, Vaseline Intensive Rescue, Tecnu Extreme, Benadryl ExtraStrength Spray and Allegra Anti-itch Cream.

June 6, 2013

The Consumer Healthcare Products Association on Thursday applauded the Vermont legislature and Gov. Peter Shumlin for their passage of House Bill 522, which makes Vermont the 27th state to adopt the pseudoephedrine-tracking system known as the National Precursor Log Exchange.

May 31, 2013

Fruth Pharmacy announced their commitment to replace medications containing pseudoephedrine, a nonprescription decongestant that can be used in the illicit manufacture of methamphetamine, with Nexafed, a PSE product formulated with Impede technology that disrupts the extraction and conversion of PSE to meth.

May 30, 2013

Westport Pharmaceuticals announced findings from independent testing of their meth-resistant pseudoephedrine product, Zephrex-D.

April 21, 2013

Westport Pharmaceuticals has been showcasing its Zephrex-D "meth-resistant" pseudoephedrine-based decongestant that is now available in retail stores throughout Missouri. It's a hot product as much for the sales generated, as for the sales not lost.

April 4, 2013

The March/April 2013 Allergy Relief Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Claritin-D, Allegra-D, Zyrtec-D, Benadryl-D, Advil Allergy and Congestion Relief, UrgentRx Allergy Attack, Hyland's Seasonal Allergy Relief, Similasan's Nasal Allergy Relief and Boiron's Sabadil.

March 6, 2013

Acura Pharmaceuticals announced that its next-generation pseudoephedrine with abuse-deterrent technology will now be stocked by North Carolina's Kerr Drug.

March 6, 2013

Prescription-only pseudoephedrine laws result in well more than $278 million in additional burdens to taxpayers, according to a study published by Matrix Global Advisors.

March 1, 2013

The Consumer Healthcare Products Association on Friday released a statement regarding a poll released last week by the Asthma and Allergy Foundation of America.

February 22, 2013

Patients around the country "strongly" oppose laws that have been proposed to change popular OTC drugs to prescription-only, according to a new survey.

February 15, 2013

According to a report filed to Congress by the Government Accountability Office on Wednesday, the seizures of methamphetamine-producing labs declined following state and federal sales restrictions on pseudoephedrine.

February 1, 2013

Novartis Consumer Health on Thursday voluntarily issued a recall of certain lots of Triaminic Syrups and Theraflu Warming Relief Syrups that were manufactured in the United States prior to Dec. 31, 2011.

January 29, 2013

Pharmacists Planning Services, Inc. earlier this month filed a Citizen's Petition with the Food and Drug Administration calling to move St. John's Wort, a mood enhancing supplement, behind the counter.

December 27, 2012

In support of its December launch of the pseudoehedrine product Nexafed, Acura Pharmaceuticals recently kicked off a national e-mail campaign to help drive pharmacists to the Nexafed website with content specifically designed for the pharmacist audience, including infographics, graphic representations of study data and a behind-the-scenes look at Nexafed's abuse-deterrent technology.

December 27, 2012

The Consumer Healthcare Products Association last week applauded Ohio Gov. John Kasich for signing into law House Bill 334, an anti-methamphetamine bill authored by Reps. Terry Johnson, R-Portsmouth, and Danny Bubp, R-West Union.

December 4, 2012

Westport Pharmaceuticals on Tuesday launched Zephrex-D, a tamper-resistant pseudoephedrine-based decongestant that is now available in retail stores throughout the St. Louis region and the state of Missouri.

November 20, 2012

Gov. Steve Beshear on Monday announced the launch of a privately funded, statewide campaign aimed at increasing public awareness about "smurfing," the illegal process of buying products containing pseudoephedrine on behalf of methamphetamine criminals.

November 15, 2012

Acura Pharmaceuticals in December will launch an immediate-release pseudoephedrine tablet under the brand name Nexafed that will help impede conversion of the tablets into methamphetamine.

November 8, 2012

Acura Pharmaceuticals on Wednesday shared with analysts details on its launch strategy of Nexafed, a pseudoephedrine formulated such that in inhibits the diversion to methamphetamnine.

October 29, 2012

Acura Pharmaceuticals in December will launch an immediate-release pseudoephedrine tablet under the brand name Nexafed that will help impede conversion of the tablets into methamphetamine.

June 21, 2012

While the picture of a new Rx-to-OTC switch paradigm is being painted with a broad stroke brush, already there are two divergent pathways emerging around what that new paradigm landscape might look like. 


June 21, 2012

Currently there are two overarching legislative issues that either threaten to place greater restrictions on certain over-the-counter medicines or fail to restore access to an OTC benefit that once played a significant role in helping develop interest in the flexible spending account plans available today.


© 2014 Drug Store News. All Rights Reserved.